Rchr
J-GLOBAL ID:200901085474976100
Update date: Nov. 20, 2024
YAMADA MITSUHIKO
ヤマダ ミツヒコ | YAMADA MITSUHIKO
Affiliation and department:
Job title:
Professor
Research field (6):
Clinical pharmacy
, Fetal medicine/Pediatrics
, Physiology
, Neuroscience - general
, Cardiology
, Pharmacology
Research keywords (14):
Excitation-contraction coupling
, Drug develpment
, Metanephrogenesis
, pediatric Heart Failure
, Circulatory Pharmacology
, Intracellular Signal Transduction System
, G protein-coupled receptor
, Heart
, Ion channels
, Intracellular calcium metabolism
, Activators
, skeletal muscle
, Intracellular signal transduction system
, Pkarmacodynamics
Research theme for competitive and other funds (47):
- 2023 - 2026 心筋細胞AT1受容体に共役する信号伝達経路の発達依存的変化の意義と機序の解明
- 2021 - 2022 離乳期までの心筋細胞AT1受容体のダイナミックな生命維持機能を活用した世界初低分子小児心不全治療薬の開発
- 2021 - Application of a beta-arrestin-biased agonist, TRV027 to pediatric heart failure
- 2018 - 2021 Identification of factors promoting final differentiation of cardiac myocytes after birth
- 2020 - βアレスチンバイアスAT1受容体アゴニストを用いた小児心不全治療法の開発
- 2020 - これまでにない方法でAT1アンジオテンシン受容体(AT1R)を利用した小児心 不全治療法の開発
- 2020 - 心筋ジャンクトフィリン2の発現・機能異常が,心不全・不整脈などの病態形成に与える影響の検討
- 2015 - 2019 Discovery of novel Nav1.7 inhibitors by using bioinformatics
- 2019 - 選択的βアレスチン刺激による小児心不全治療法の開発
- 2018 - 小児心不全の新しい治療法の開発
- 2018 - サルコペニアにおいて筋力低下が生じるメカニズムの解明
- 2018 - 小児心不全の新しい薬物療法の開発
- 2018 - βアレスチンバイアスAT1受容体アゴニストを用いた小児心不全治療法の開発
- 2018 - AT1アンジオテンシン受容体βアレスチンバイアスアゴニストが若年性心不全に与える効果の検討
- 2014 - 2017 Elucidation of epigenetic regulation of gene expresson involved in maintaining cardiac function and metabolism
- 2013 - 2016 Changes in expression of L-type calcium channel subunits in skeletal muscle with aging.
- 2016 - 心不全の心室筋細胞でのL型Ca2+チャネルのリモデリングに関する研究
- 2012 - 2015 Localization and function of L-type calcium channels in skeletal muscle is regulated by junctophilins.
- 2009 - 2011 Quantitative analysis of the open-state affinity of L-type calcium channel blockers and modeling of their inhibitory actions
- 2004 - 2006 Analysis of the molecular mechanism underlying the regulation of ATP-sensitive K+ channels by drugs
- 2003 - 2005 Molecular mechanisms for functional and spatial regulation of the G protein-gated potassium channel
- 2002 - 2004 Regeneration of myocardium using bone marrow cells for the treatment of severe heart failure
- 2000 - 2002 Role of Muscarinic K Channels in Parasympthetic Regulation of Heart Beat
- 1998 - 1998 動脈硬化血管の収縮異常と血管平滑筋型ATP感受性K^+チャネル
- 1997 - 1998 Investigation of Molecular Diversity of ATP-Sensitive K^+ Channels.
- 1997 - 1998 Its functional significance and molecular mechanism
- 1996 - 1998 Studies of inwardly rectifying K^+ channels and an approach to develop new methods for assaying K^+ channel activity.
- 1995 - 1998 Molecular Mechanism in Regulation of Inwardly Rectifying Potassium Channel and its Functional Disorder
- 1996 - 1997 Analysis of the polyamine-binding sites in inwardly rectifying K^+ channels.
- 1995 - 1996 Molecular Analysis of Inward Rectifier K^+channels in CNS
- 1994 - 1996 Molecular cloning of ATP-sensitive K^+ channels and development of the method evaluating K^+ channel openers.
- 1995 - 1995 内向き整流カリウムチャネルの細胞内物質によるゲーティング機構の解析
- 1995 - 1995 内向き整流特性カリウムチャネルの神経伝達調節と可塑性における役割
- 1995 - 1995 3量体G蛋白による心筋細胞カリウムチャネル制御の分子機構
- 1994 - 1994 心筋細胞ATP依存性カリウムチャネルの受容体および機械刺激依存性制御とその異常
- 1994 - 1994 三量体G蛋白質による心筋細胞カリウムチャネル制御の分子機構
- 1994 - 1994 NOによる中枢神経細胞内向き整流カリウムチャネルの抑制性修飾とその分子機構
- 1988 - 1989 Regulatory mechanisms of receptor-coupled signal transduction and its pathophysiologic state
- Investigation of the mechanism underlying metanephrogenesis
- Development of therapeutics for pediatric heart failure
- 小児心不全の新しい治療法の開発
- 小児心不全の新しい薬物療法の開発
- βアレスチンバイアスAT1受容体アゴニストを用いた小児心不全治療法の開発
- AT1アンジオテンシン受容体βアレスチンバイアスアゴニストが若年性心不全に与える効果の検討
- βアレスチンバイアスAT1受容体アゴニストを用いた小児心不全治療法の開発
- AT1アンジオテンシン受容体βアレスチンバイアスアゴニストが若年性心不全に与える効果の検討
- Physiological, pathophysiological and pharmacological analyses of cardiac L-type Ca2+ channels
Show all
Papers (129):
-
Yuki Tanaka, Shin Kadota, Jian Zhao, Hideki Kobayashi, Satomi Okano, Masaki Izumi, Yusuke Honda, Hajime Ichimura, Naoko Shiba, Takeshi Uemura, et al. Mature human induced pluripotent stem cell-derived cardiomyocytes promote angiogenesis through alpha-B crystallin. Stem cell research & therapy. 2023. 14. 1. 240-240
-
KAWAGISHI Hiroyuki, YAMADA Mitsuhiko. Role of Cytokine Receptor gp130 in Functional Development of the Neonatal Mouse Heart. THE SHINSHU MEDICAL JOURNAL. 2022. 70. 6. 373-382
-
Takashi Murayama, Nagomi Kurebayashi, Takuro Numaga-Tomita, Takuya Kobayashi, Satoru Okazaki, Kyosuke Yamashiro, Tsutomu Nakada, Shuichi Mori, Ryosuke Ishida, Hiroyuki Kagechika, et al. A reconstituted depolarization-induced Ca2+ release platform for validation of skeletal muscle disease mutations and drug discovery. The Journal of general physiology. 2022. 154. 12
-
Hiroyuki Kawagishi, Tsutomu Nakada, Takuro Numaga-Tomita, Maite Larrañaga, Ang Guo, Long-Sheng Song, Mitsuhiko Yamada. Cytokine receptor gp130 promotes postnatal proliferation of cardiomyocytes required for the normal functional development of the heart. American Journal of Physiology-Heart and Circulatory Physiology. 2022
-
Hideaki Inazumi, Koichiro Kuwahara, Yasuaki Nakagawa, Yoshihiro Kuwabara, Takuro Numaga-Tomita, Toshihide Kashihara, Tsutomu Nakada, Nagomi Kurebayashi, Miku Oya, Miki Nonaka, et al. NRSF-GNAO1 Pathway Contributes to the Regulation of Cardiac Ca2+ Homeostasis. Circulation research. 2022. 130. 2. 234-248
more...
MISC (78):
-
βアレスチンバイアスAT1受容体アゴニストは新しい乳幼児心不全治療薬の有力候補である。. 医学のあゆみ. 2021. 276. 12. 1137-1138
-
川岸裕幸, 柏原俊英, 冨田拓郎, 中田勉, 山田充彦. アンジオテンシンII1型受容体-βアレスチン経路を活性化する小児心不全治療薬の開発. 日本循環薬理学会口演要旨集. 2020. 30th
-
冨田拓郎, 五味志文, 柏原俊英, 中田勉, 山田充彦. Molecular mechanisms underlying the agonistic effect of FPL 64176 on Cav1.2 Ca2+ channels. 日本薬理学雑誌. 2020. 155. Supplement
-
川岸裕幸, 川岸裕幸, 柏原俊英, 冨田拓郎, 中田勉, 山田充彦. βアレスチンバイアスアンジオテンシン1型受容体アゴニストは,新生児特有の持続性陽性変力作用を示す. 日本薬理学雑誌. 2020. 155. Supplement
-
川岸裕幸, 川岸裕幸, 柏原俊英, 中田勉, 冨田拓郎, 山田充彦. βアレスチンバイアスアンジオテンシン1型受容体アゴニストは,新生児マウス心臓において持続的な陽性変力作用を示す. 日本循環薬理学会口演要旨集. 2019. 29th
more...
Books (2):
-
熱血 循環器学 洋學社 井上信孝編集
洋學社 2019
-
倉智 嘉久編:別冊・医学のあゆみイオンチャネル最前線update
医歯薬出版株式会社,東京 2005
Lectures and oral presentations (18):
-
Postnatal loss of gp130 caused impaired cardiac contractility accompanied by inhibition of physiological proliferation of cardiomyocytes.
(NIPS International Meeting on Cardiovascular Physiology 2020 2020)
-
Molecular mechanism underlying cardiac early afterdepolarization induced by IKr and IKs suppression.
(The 11th Annual Meeting of Japanese Safety Pharmacology Society 2020)
-
新生児マウスにおける、gp130受容体を介した心筋細胞の発達機構
(筋生理の集い 2019)
-
A beta arrestin-bias AT1 receptor agonist improves the survival of neonatal knock-in mice bearing a human dilated cardiomyopathy mutation.
(The 50th NIPS International Symposium. ‘MIRACLES’ in Cardiovascular Physiology 2019)
-
βアレスチンバイアスアンジオテンシン1型受容体アゴニストは、新生児マウス心臓において持続的な陽性変力作用を示す
(第29回日本循環薬理学会 2019)
more...
Education (1):
- 1978 - 1984 Kobe University Faculty of Medicine School of Medicine
Professional career (1):
Work history (4):
- 2004/07/01 - Professor, Dept. Mol. Pharamacol. Shinshu Univ. Sch. Med.
- 2002/06/01 - 2004/06/30 Associate Professor, Dept. Pharamacol. II, Osaka Univ. Grad. Sch. Med.
- 1998/04/01 - 2002/05/31 Assitant Professor, Dept. Card. Physiol., National Cardiovasc. Ctr. Res. Inst.
- 1994/04/01 - 1998/03/31 Assistant Professor, Dept. Pharmacol. II, Osaka Univ. Sch. Med.
Committee career (1):
Awards (2):
- 2005/10/07 - 第5回医科学応用研究財団助成による日本心電学会論文賞
- 1993/01/15 - 財団法人循環器学研究振興財団内田賞
Association Membership(s) (8):
Japanese Society of Pediatric Cardiology and Cardiac Surgery
, Japanese Society of Pharmacology
, ISHR
, The American Physiological Society
, Biophysical Society
, The Japanese Society of Electrocardiology
, Physiological Society of Japan
, The Japanese Circulation Society
Return to Previous Page